Optimizing age-specific vaccination

Science. 2021 Feb 26;371(6532):890-891. doi: 10.1126/science.abg2334. Epub 2021 Jan 21.

Authors

Meagan C Fitzpatrick^{1

2}, Alison P Galvani³

Affiliations

¹ Center for Vaccine Development and Global Health, University of Maryland School of Medicine, Baltimore, MD, USA.
² Center for Infectious Disease Modeling and Analysis, Yale School of Public Health, New Haven, CT, USA.
³ Center for Infectious Disease Modeling and Analysis, Yale School of Public Health, New Haven, CT, USA. alison.galvani@yale.edu.

PMID: 33479122
DOI: 10.1126/science.abg2334

No abstract available

Publication types

Comment

MeSH terms

Age Factors
COVID-19 Vaccines*
COVID-19*
Humans
SARS-CoV-2
Vaccination

Substances

COVID-19 Vaccines